Planned Parenthood Federation of America
17
2
2
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
5.9%
1 terminated/withdrawn out of 17 trials
92.9%
+6.4% vs industry average
29%
5 trials in Phase 3/4
46%
6 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
Role: collaborator
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
Role: collaborator
Levonorgestrel Intrauterine System For Emergency Contraception
Role: collaborator
Determining Beta-hCG Levels in Patients Through Alternative Sample Types
Role: collaborator
Improving Contraceptive Counseling in the United States
Role: collaborator
Evaluating a Digital Health Information Tool
Role: collaborator
Cluster, Randomized Trial on Long Acting Reversible Contraception (LARC) Education and Training
Role: collaborator
A Narrative Intervention to Decrease Abortion Stigma
Role: collaborator
Paracervical Block for Pain Control in First Trimester Abortion
Role: collaborator
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Role: collaborator
Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood
Role: lead
Paracervical Block for Pain Control With Osmotic Dilator Placement
Role: collaborator
Hydrocodone For Pain Control in First Trimester Surgical Abortion
Role: collaborator
Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series
Role: lead
Contraceptive Equity Study 2016
Role: lead
Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate
Role: collaborator
De-Medicalizing Mifepristone Medical Abortion
Role: collaborator
All 17 trials loaded